Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 61

1.

Carnitine administration reduces cytokine levels, improves food intake, and ameliorates body composition in tumor-bearing rats.

Laviano A, Molfino A, Seelaender M, Frascaria T, Bertini G, Ramaccini C, Bollea MR, Citro G, Rossi Fanelli F.

Cancer Invest. 2011 Dec;29(10):696-700. doi: 10.3109/07357907.2011.626476.

PMID:
22085273
2.

Randomised clinical trial: the efficacy and safety of propionyl-L-carnitine therapy in patients with ulcerative colitis receiving stable oral treatment.

Mikhailova TL, Sishkova E, Poniewierka E, Zhidkov KP, Bakulin IG, Kupcinskas L, Lesniakowski K, Grinevich VB, Malecka-Panas E, Ardizzone S, D'Arienzo A, Valpiani D, Koch M, Denapiene G, Vago G, Fociani P, Zerbi P, Ceracchi M, Camerini R, Gasbarrini G.

Aliment Pharmacol Ther. 2011 Nov;34(9):1088-97. doi: 10.1111/j.1365-2036.2011.04844.x. Epub 2011 Sep 19.

3.

Protective effects of L-carnitine on intestinal ischemia/reperfusion injury in a rat model.

Yuan Y, Guo H, Zhang Y, Zhou D, Gan P, Liang DM, Chen JY.

J Clin Med Res. 2011 Apr 4;3(2):78-84. doi: 10.4021/jocmr540w.

4.

Contribution of the IBD5 locus to inflammatory bowel disease: a meta-analysis.

Wang J, Wang X, Yang H, Wu D, Wang L, Qian J.

Hum Genet. 2011 Jun;129(6):597-609. doi: 10.1007/s00439-011-0952-6. Epub 2011 Jan 30.

PMID:
21279723
5.

Necrotizing enterocolitis.

Neu J, Walker WA.

N Engl J Med. 2011 Jan 20;364(3):255-64. doi: 10.1056/NEJMra1005408. Review. No abstract available.

6.

TGF-β2 suppresses macrophage cytokine production and mucosal inflammatory responses in the developing intestine.

Maheshwari A, Kelly DR, Nicola T, Ambalavanan N, Jain SK, Murphy-Ullrich J, Athar M, Shimamura M, Bhandari V, Aprahamian C, Dimmitt RA, Serra R, Ohls RK.

Gastroenterology. 2011 Jan;140(1):242-53. doi: 10.1053/j.gastro.2010.09.043. Epub 2010 Sep 24.

7.

L-carnitine, a diet component and organic cation transporter OCTN ligand, displays immunosuppressive properties and abrogates intestinal inflammation.

Fortin G, Yurchenko K, Collette C, Rubio M, Villani AC, Bitton A, Sarfati M, Franchimont D.

Clin Exp Immunol. 2009 Apr;156(1):161-71. doi: 10.1111/j.1365-2249.2009.03879.x. Epub 2009 Jan 23.

8.

L-carnitine mediates protection against DNA damage in lymphocytes of aged rats.

Thangasamy T, Jeyakumar P, Sittadjody S, Joyee AG, Chinnakannu P.

Biogerontology. 2009 Apr;10(2):163-72. doi: 10.1007/s10522-008-9159-1. Epub 2008 Jul 16.

PMID:
18629605
9.

Spontaneous development of intestinal and colonic atrophy and inflammation in the carnitine-deficient jvs (OCTN2(-/-)) mice.

Shekhawat PS, Srinivas SR, Matern D, Bennett MJ, Boriack R, George V, Xu H, Prasad PD, Roon P, Ganapathy V.

Mol Genet Metab. 2007 Dec;92(4):315-24. Epub 2007 Sep 19.

10.

Prevention and treatment of necrotising enterocolitis in preterm neonates.

Patole S.

Early Hum Dev. 2007 Oct;83(10):635-42. Epub 2007 Sep 10. Review.

PMID:
17826009
11.

Blockade of TGF-beta accelerates mucosal destruction through epithelial cell apoptosis.

Sakuraba H, Ishiguro Y, Yamagata K, Munakata A, Nakane A.

Biochem Biophys Res Commun. 2007 Aug 3;359(3):406-12. Epub 2007 May 30.

PMID:
17560553
12.

Neurodevelopmental outcomes of very low-birth-weight infants with necrotizing enterocolitis: a systematic review of observational studies.

Schulzke SM, Deshpande GC, Patole SK.

Arch Pediatr Adolesc Med. 2007 Jun;161(6):583-90. Review.

PMID:
17548764
13.

Early human milk feeding is associated with a lower risk of necrotizing enterocolitis in very low birth weight infants.

Sisk PM, Lovelady CA, Dillard RG, Gruber KJ, O'Shea TM.

J Perinatol. 2007 Jul;27(7):428-33. Epub 2007 Apr 19. Erratum in: J Perinatol. 2007 Dec;27(12):808.

PMID:
17443195
14.

Transforming growth factor-beta: an important cytokine in the mucosal immune response.

Ohtsuka Y, Sanderson IR.

Curr Opin Gastroenterol. 2000 Nov;16(6):541-5.

PMID:
17031135
15.

Prevalence of SLC22A4, SLC22A5 and CARD15 gene mutations in Hungarian pediatric patients with Crohn's disease.

Bene J, Magyari L, Talián G, Komlósi K, Gasztonyi B, Tari B, Várkonyi A, Mózsik G, Melegh B.

World J Gastroenterol. 2006 Sep 14;12(34):5550-3.

16.

Neurodevelopmental outcomes of neonates with medically and surgically treated necrotizing enterocolitis.

Rees CM, Pierro A, Eaton S.

Arch Dis Child Fetal Neonatal Ed. 2007 May;92(3):F193-8. Epub 2006 Sep 19. Review.

17.

Relative bioavailability of carnitine supplementation in premature neonates.

Crill CM, Christensen ML, Storm MC, Helms RA.

JPEN J Parenter Enteral Nutr. 2006 Sep-Oct;30(5):421-5.

PMID:
16931611
18.

Does necrotising enterocolitis impact the neurodevelopmental and growth outcomes in preterm infants with birthweight < or =1250 g?

Soraisham AS, Amin HJ, Al-Hindi MY, Singhal N, Sauve RS.

J Paediatr Child Health. 2006 Sep;42(9):499-504.

PMID:
16925534
19.

Direct or indirect association in a complex disease: the role of SLC22A4 and SLC22A5 functional variants in Crohn disease.

Fisher SA, Hampe J, Onnie CM, Daly MJ, Curley C, Purcell S, Sanderson J, Mansfield J, Annese V, Forbes A, Lewis CM, Schreiber S, Rioux JD, Mathew CG.

Hum Mutat. 2006 Aug;27(8):778-85.

PMID:
16835882
20.

Contribution of OCTN variants within the IBD5 locus to pediatric onset Crohn's disease.

Babusukumar U, Wang T, McGuire E, Broeckel U, Kugathasan S.

Am J Gastroenterol. 2006 Jun;101(6):1354-61.

PMID:
16771961

Supplemental Content

Support Center